BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 10525080)

  • 1. Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a xenopus oocyte expression system.
    McAllister SD; Griffin G; Satin LS; Abood ME
    J Pharmacol Exp Ther; 1999 Nov; 291(2):618-26. PubMed ID: 10525080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons.
    Guo J; Ikeda SR
    Mol Pharmacol; 2004 Mar; 65(3):665-74. PubMed ID: 14978245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes.
    Henry DJ; Chavkin C
    Neurosci Lett; 1995 Feb; 186(2-3):91-4. PubMed ID: 7777206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cannabinoid receptor agonists, anandamide and WIN 55,212-2, do not directly affect mu opioid receptors expressed in Xenopus oocytes.
    Kracke GR; Stoneking SP; Ball JM; Tilghman BM; Washington CC; Hotaling KA; Johnson JO; Tobias JD
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Dec; 376(4):285-93. PubMed ID: 17960365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition by various antipsychotic drugs of the G-protein-activated inwardly rectifying K(+) (GIRK) channels expressed in xenopus oocytes.
    Kobayashi T; Ikeda K; Kumanishi T
    Br J Pharmacol; 2000 Apr; 129(8):1716-22. PubMed ID: 10780978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system.
    Griffin G; Wray EJ; Tao Q; McAllister SD; Rorrer WK; Aung MM; Martin BR; Abood ME
    Eur J Pharmacol; 1999 Jul; 377(1):117-25. PubMed ID: 10448934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.
    Breivogel CS; Griffin G; Di Marzo V; Martin BR
    Mol Pharmacol; 2001 Jul; 60(1):155-63. PubMed ID: 11408610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of clozapine on the delta- and kappa-opioid receptors and the G-protein-activated K+ (GIRK) channel expressed in Xenopus oocytes.
    Kobayashi T; Ikeda K; Kumanishi T
    Br J Pharmacol; 1998 Feb; 123(3):421-6. PubMed ID: 9504382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterologous facilitation of G protein-activated K(+) channels by beta-adrenergic stimulation via cAMP-dependent protein kinase.
    Müllner C; Vorobiov D; Bera AK; Uezono Y; Yakubovich D; Frohnwieser-Steinecker B; Dascal N; Schreibmayer W
    J Gen Physiol; 2000 May; 115(5):547-58. PubMed ID: 10779313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes.
    Sagan S; Venance L; Torrens Y; Cordier J; Glowinski J; Giaume C
    Eur J Neurosci; 1999 Feb; 11(2):691-9. PubMed ID: 10051770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing the G-protein regulation of GIRK1 and GIRK4, the two subunits of the KACh channel, using functional homomeric mutants.
    Vivaudou M; Chan KW; Sui JL; Jan LY; Reuveny E; Logothetis DE
    J Biol Chem; 1997 Dec; 272(50):31553-60. PubMed ID: 9395492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins.
    Lauckner JE; Hille B; Mackie K
    Proc Natl Acad Sci U S A; 2005 Dec; 102(52):19144-9. PubMed ID: 16365309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanosensitivity of GIRK channels is mediated by protein kinase C-dependent channel-phosphatidylinositol 4,5-bisphosphate interaction.
    Zhang L; Lee JK; John SA; Uozumi N; Kodama I
    J Biol Chem; 2004 Feb; 279(8):7037-47. PubMed ID: 14660621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slow modal gating of single G protein-activated K+ channels expressed in Xenopus oocytes.
    Yakubovich D; Pastushenko V; Bitler A; Dessauer CW; Dascal N
    J Physiol; 2000 May; 524 Pt 3(Pt 3):737-55. PubMed ID: 10790155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
    Castelli MP; Paola Piras A; D'Agostino A; Pibiri F; Perra S; Gessa GL; Maccarrone M; Pistis M
    Eur J Pharmacol; 2007 Nov; 573(1-3):11-9. PubMed ID: 17644084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CB1 cannabinoid receptor-dependent and -independent inhibition of depolarization-induced calcium influx in oligodendrocytes.
    Mato S; Alberdi E; Ledent C; Watanabe M; Matute C
    Glia; 2009 Feb; 57(3):295-306. PubMed ID: 18814177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A C-terminal peptide of the GIRK1 subunit directly blocks the G protein-activated K+ channel (GIRK) expressed in Xenopus oocytes.
    Luchian T; Dascal N; Dessauer C; Platzer D; Davidson N; Lester HA; Schreibmayer W
    J Physiol; 1997 Nov; 505 ( Pt 1)(Pt 1):13-22. PubMed ID: 9409468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cannabinoid agonist WIN 55,212-2 inhibits TNF-alpha-induced neutrophil transmigration across ECV304 cells.
    Nilsson O; Fowler CJ; Jacobsson SO
    Eur J Pharmacol; 2006 Oct; 547(1-3):165-73. PubMed ID: 16928371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural mimicry in class A G protein-coupled receptor rotamer toggle switches: the importance of the F3.36(201)/W6.48(357) interaction in cannabinoid CB1 receptor activation.
    McAllister SD; Hurst DP; Barnett-Norris J; Lynch D; Reggio PH; Abood ME
    J Biol Chem; 2004 Nov; 279(46):48024-37. PubMed ID: 15326174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dual modulation of GIRK1/GIRK2 channels by opioid receptor ligands.
    Ulens C; Daenens P; Tytgat J
    Eur J Pharmacol; 1999 Dec; 385(2-3):239-45. PubMed ID: 10607882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.